BBA
Baker Bros. Advisors’s AbCellera Biologics ABCL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $94.4M | Hold |
27,525,640
| – | – | 0.92% | 14 |
|
|
2025
Q1 | $61.4M | Hold |
27,525,640
| – | – | 0.68% | 18 |
|
|
2024
Q4 | $80.7M | Hold |
27,525,640
| – | – | 0.86% | 17 |
|
|
2024
Q3 | $71.6M | Hold |
27,525,640
| – | – | 0.74% | 20 |
|
|
2024
Q2 | $81.5M | Hold |
27,525,640
| – | – | 1.04% | 16 |
|
|
2024
Q1 | $125M | Buy |
27,525,640
+4,615,887
| +20% | +$20.9M | 1.56% | 8 |
|
|
2023
Q4 | $131M | Buy |
22,909,753
+2,146,430
| +10% | +$12.3M | 1.49% | 11 |
|
|
2023
Q3 | $95.5M | Buy |
20,763,323
+4,313,143
| +26% | +$19.8M | 0.55% | 12 |
|
|
2023
Q2 | $106M | Buy |
16,450,180
+6,000,000
| +57% | +$38.8M | 0.62% | 14 |
|
|
2023
Q1 | $78.8M | Hold |
10,450,180
| – | – | 0.43% | 15 |
|
|
2022
Q4 | $106M | Hold |
10,450,180
| – | – | 0.64% | 16 |
|
|
2022
Q3 | $103M | Hold |
10,450,180
| – | – | 0.68% | 12 |
|
|
2022
Q2 | $111M | Hold |
10,450,180
| – | – | 0.63% | 11 |
|
|
2022
Q1 | $102M | Hold |
10,450,180
| – | – | 0.59% | 13 |
|
|
2021
Q4 | $149M | Hold |
10,450,180
| – | – | 0.73% | 13 |
|
|
2021
Q3 | $209M | Hold |
10,450,180
| – | – | 0.92% | 12 |
|
|
2021
Q2 | $230M | Hold |
10,450,180
| – | – | 1.01% | 12 |
|
|
2021
Q1 | $355M | Hold |
10,450,180
| – | – | 1.54% | 11 |
|
|
2020
Q4 | $421M | Buy |
+10,450,180
| New | +$421M | 1.58% | 11 |
|